XML 90 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Collaboration Agreements (Takeda Collaboration, Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Jan. 03, 2020
Sep. 27, 2019
Jun. 28, 2019
Mar. 29, 2019
Dec. 28, 2018
Sep. 29, 2018
Jun. 29, 2018
Mar. 31, 2018
Jan. 03, 2020
Dec. 28, 2018
Dec. 29, 2017
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Milestone payments earned $ 15,100,000 $ 50,600,000 $ 20,400,000 $ 10,000,000.0 $ 29,600,000 $ 42,600,000 $ 25,800,000 $ 66,500,000      
Remaining performance obligation 63,100,000               $ 63,100,000    
Collaborative arrangement with Takeda                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Sales volume period                 6 years    
Upfront payments                     $ 50,000,000.0
Milestone payments earned to date 26,000,000.0               $ 26,000,000.0    
Milestone payments earned                 16,000,000.0 $ 10,000,000.0  
Eligible payment from collaboration for development and regulatory milestone achievement under collaborations agreement 10,000,000.0               10,000,000.0    
Maximum amount eligible for development and regulatory milestones 20,000,000.0               20,000,000.0    
Maximum amount eligible for commercial milestones under collaborations agreement 155,000,000.0               155,000,000.0    
Net contract liability 24,600,000       $ 18,000,000.0       24,600,000 $ 18,000,000.0 $ 14,800,000
Remaining performance obligation $ 18,100,000               $ 18,100,000    
Collaborative arrangement with Takeda | Global                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Research and development arrangement performed for others, reimbursement for costs incurred, percent                 20.00%    
Collaborative arrangement with Takeda | Japan                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Collaboration period to achieve specified levels of commercial performance                 2 years    
Research and development arrangement performed for others, reimbursement for costs incurred, percent                 100.00%    
Collaborative arrangement with Takeda | Initial                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Royalty tier                 $ 300,000,000.0    
Collaborative arrangement with Takeda | Minimum | Initial                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Percent of royalty on net sale                 15.00%    
Collaborative arrangement with Takeda | Minimum | Final tier                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Percent of royalty on net sale                 20.00%    
Collaborative arrangement with Takeda | Maximum | Initial                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Percent of royalty on net sale                 24.00%    
Collaborative arrangement with Takeda | Maximum | Final tier                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Percent of royalty on net sale                 30.00%    
ASU 2014-09 | Adjustments Due to the Adoption of Topic 606 | EMA Filing Acceptance - HCC | Collaborative arrangement with Takeda                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Milestone payments earned               $ 10,000,000.0